Enveric Biosciences, Inc. ENVB

1.50 (0.05) (3.23%) as of 25 Sep

Follow ENVB

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(235.48%)	(257.95%)	(420.48%)	(303.64%)	+8 more TTM periods Free account
ROA Full definition →	(193.53%)	(218.01%)	(296.67%)	(245.75%)
ROIC Full definition →	0.00%	(3,379.93%)	0.00%	0.00%
Return on Tangible Assets Full definition →	(150.85%)	(230.02%)	(290.40%)	(325.39%)
Average Days of Receivables Full definition →	—	—	—	—
Free Cash Flow per Share Full definition →	(2.15)	(5.30)	(24.32)	(24.48)
Free Cash Flow Full definition →	(8.56)	(8.01)	(8.14)	(7.67)
Other line items
Cash ROIC Full definition →	(52.27%)	(80.31%)	(91.94%)	(106.30%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →	0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →	0.71	0.69	0.67	0.68
Depreciation/Fixed assets Full definition →	1.88	1.31	1.26	1.24
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(2.15)	(5.30)	(24.32)	(24.48)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Net Profit Margin Full definition →	0.00%	0.00%	0.00%	0.00%

Columns are period end dates

Powerpack